Isthmus Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Isthmus Partners's AMGN Position: Q4 2023 in Review
Isthmus Partners sold out of Amgen (AMGN) in Q4 2023, closing a stake of 800 shares — an estimated $215K sold.
Isthmus Partners first reported a position in AMGN in Q4 2014 and held it in 21 quarters. The position peaked at $936K in Q1 2019. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.
- Isthmus Partners reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
- Isthmus Partners sold 800 Amgen shares in Q4 2023, an estimated $215K.
- Isthmus Partners first reported a position in Amgen in Q4 2014 and held it in 21 quarters.
- Isthmus Partners's Amgen position peaked at $936K in Q1 2019.
- 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.
Based on Isthmus Partners's 13F filing for Q4 2023, filed 12 Feb 2024.